Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Variant Pharmaceuticals Logo
Variant Pharmaceuticals Growth Score
26
CB Rank
101481
Heat Score
47
Variant Pharmaceuticals is a specialty pharmaceutical company utilizing proprietary technologies to create and develop.
Founded
obfuscation
PrivateVenture - Series Unknown Weston, Florida, United States1-10 www.variantpharma.com
Biotechnology
Health Care
Pharmaceutical
Wellness
Overview

Variant Pharmaceuticals
Total Funding
obfuscation
Growth Score
26
Heat Score
47

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score26
-5 pts
in past quarter
Heat Score 47
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Variant Pharmaceuticals

CB Rank
101481
Variant Pharmaceuticals is a specialty pharmaceutical company utilizing proprietary technologies to create and develop.
Founded
obfuscation
PrivateVenture - Series Unknown Weston, Florida, United States1-10 www.variantpharma.com
Biotechnology
Health Care
Pharmaceutical
Wellness

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

  • Photo of Stephen C. Glover
    Stephen C. Glover: Co-Founder, CEO, President and Director
    Past Role: Coherus Biosciences, Co-Founder and Chief Business Officer

Details

Legal Name Variant Pharmaceuticals, Inc.
Operating Status Active
Company Type For Profit
Founders  Shawn Titcomb, Stephen C. Glover
About the Company

Variant is a development stage specialty pharmaceutical company utilizing proprietary technologies to create and develop formulations that result in improved therapies for patients. With more than 120 years of biopharmaceutical industry expertise, the Variant team is focused on developing and commercializing products for the treatment of Men’s

Health, as well as large and growing markets where current therapies are suboptimal or underdeveloped.

Phone Number (954) 529-2109
Predictions & Insights

Products & Services

IC 100
A monoclonal antibody that inhibits the ASC component of inflammasomes to block the initiation and perpetuation of the inflammatory cascade.
VAR 200
A cholesterol efflux mediator that removes excess cholesterol from the kidney's filtration system to protect against structural damage, reduce proteinuria, and preserve function.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown
obfuscation
Venture Round - Variant Pharmaceuticals Logo
Venture Round - Variant Pharmaceuticals
1
obfuscation
INCON Co.Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 265

Employee Profiles

News

News and Press

News•Aug 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 16, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Actively Used Products

4Variant Pharmaceuticals uses 4 technology products and services including HTML5, DigiCert, and  Modernizr, according to G2 Stack.

Active Website Tech Count

11Variant Pharmaceuticals is actively using 11 technologies for its website, according to BuiltWith. These include SPF, U.S. Server Location, and  Amazon.

Total IP

1Variant Pharmaceuticals has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Variant Pharmaceuticals's headquarters? Variant Pharmaceuticals is located in Weston, Florida, United States.Who invested in Variant Pharmaceuticals? Variant Pharmaceuticals is funded by INCON Co..When was the last funding round for Variant Pharmaceuticals? Variant Pharmaceuticals closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Variant Pharmaceuticals's competitors? Alternatives and possible competitors to Variant Pharmaceuticals may include Travere Therapeutics, Vigil Neuroscience, and  NodThera.How much funding has Variant Pharmaceuticals raised to date? Variant Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|